Literature DB >> 22052043

Delivering a pharmacogenetic service: is there a role for genetic counselors?

Alice Callard1, William Newman, Katherine Payne.   

Abstract

Pharmacogenetics, the use of genetic information to direct safer and or more effective prescription of medication, is a relatively new clinical concept. Currently, there is no consensus regarding which healthcare professionals should deliver pharmacogenetic services. This study explored the opinions of genetic counselors about their potential role in delivering pharmacogenetic services. Semi-structured face-to-face interviews were conducted with 14 genetic counselors. Four vignettes describing pharmacogenetic testing scenarios were used to elicit views on specific clinical applications. Data were analysed using the constant comparative method. Opinions varied, but the majority of interviewees suggested that genetic counselors could have a role. However, participants suggested that additional training would be needed due to counselors' limited knowledge of pharmacogenetics. Employing genetic counselors in a specialist role within a multidisciplinary clinic was suggested as a model of service delivery. Service models developed for pharmacogenetic testing may need to be adapted according to the issues presented by each type of test.

Entities:  

Mesh:

Year:  2011        PMID: 22052043     DOI: 10.1007/s10897-011-9415-4

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  37 in total

Review 1.  Inheritance and drug response.

Authors:  Richard Weinshilboum
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

2.  Pharmacogenetics: ethical issues and policy options.

Authors:  Allen Buchanan; Andrea Califano; Jeffrey Kahn; Elizabeth McPherson; John Robertson; Baruch Brody
Journal:  Kennedy Inst Ethics J       Date:  2002-03

Review 3.  Pharmacogenomics: bench to bedside.

Authors:  Richard Weinshilboum; Liewei Wang
Journal:  Nat Rev Drug Discov       Date:  2004-09       Impact factor: 84.694

4.  The prospect of genome-guided preventive medicine: a need and opportunity for genetic counselors.

Authors:  Julianne M O'Daniel
Journal:  J Genet Couns       Date:  2010-05-04       Impact factor: 2.537

5.  A new definition of Genetic Counseling: National Society of Genetic Counselors' Task Force report.

Authors:  Robert Resta; Barbara Bowles Biesecker; Robin L Bennett; Sandra Blum; Susan Estabrooks Hahn; Michelle N Strecker; Janet L Williams
Journal:  J Genet Couns       Date:  2006-04       Impact factor: 2.537

6.  Putting pharmacogenetics into practice.

Authors:  Michael M Hopkins; Dolores Ibarreta; Sibylle Gaisser; Christien M Enzing; Jim Ryan; Paul A Martin; Graham Lewis; Symone Detmar; M Elske van den Akker-van Marle; Adam M Hedgecoe; Paul Nightingale; Marieke Dreiling; K Juliane Hartig; Wieneke Vullings; Tony Forde
Journal:  Nat Biotechnol       Date:  2006-04       Impact factor: 54.908

7.  The GNB3 C825T polymorphism and essential hypertension: a meta-analysis of 34 studies including 14,094 cases and 17,760 controls.

Authors:  Pantelis G Bagos; Antigoni L Elefsinioti; Georgios K Nikolopoulos; Stavros J Hamodrakas
Journal:  J Hypertens       Date:  2007-03       Impact factor: 4.844

8.  Pharmacogenetic testing for drug metabolizing enzymes: is it happening in practice?

Authors:  Sharon J Gardiner; Evan J Begg
Journal:  Pharmacogenet Genomics       Date:  2005-05       Impact factor: 2.089

9.  Association of G-protein beta-3 subunit gene (GNB3) T825 allele with Type II diabetes.

Authors:  Jawad G Kiani; Mohammad Saeed; S Hassan Parvez; Philippe M Frossard
Journal:  Neuro Endocrinol Lett       Date:  2005-04       Impact factor: 0.765

Review 10.  Tamoxifen pharmacogenomics: the role of CYP2D6 as a predictor of drug response.

Authors:  M P Goetz; A Kamal; M M Ames
Journal:  Clin Pharmacol Ther       Date:  2007-09-19       Impact factor: 6.875

View more
  8 in total

1.  Implementation of a clinical research pharmacogenomics program at an academic medical center: role of the genetics healthcare professional.

Authors:  Amy Curry Sturm; Kevin Sweet; Kandamurugu Manickam
Journal:  Pharmacogenomics       Date:  2013-05       Impact factor: 2.533

2.  Non-invasive prenatal testing: UK genetic counselors' experiences and perspectives.

Authors:  Elizabeth Alexander; Susan Kelly; Lauren Kerzin-Storrar
Journal:  J Genet Couns       Date:  2014-10-15       Impact factor: 2.537

3.  Clinical delivery of pharmacogenetic testing services: a proposed partnership between genetic counselors and pharmacists.

Authors:  Rachel Mills; Susanne B Haga
Journal:  Pharmacogenomics       Date:  2013-06       Impact factor: 2.533

4.  Nurses' communication of pharmacogenetic test results as part of discharge care.

Authors:  Susanne B Haga; Rachel Mills
Journal:  Pharmacogenomics       Date:  2015       Impact factor: 2.533

Review 5.  The composition and capacity of the clinical genetics workforce in high-income countries: a scoping review.

Authors:  Nick Dragojlovic; Kennedy Borle; Nicola Kopac; Ursula Ellis; Patricia Birch; Shelin Adam; Jan M Friedman; Amy Nisselle; Alison M Elliott; Larry D Lynd
Journal:  Genet Med       Date:  2020-06-24       Impact factor: 8.822

6.  Pharmacogenomic knowledge gaps and educational resource needs among physicians in selected specialties.

Authors:  Katherine A Johansen Taber; Barry D Dickinson
Journal:  Pharmgenomics Pers Med       Date:  2014-07-10

Review 7.  Pharmacogenomic testing to support prescribing in primary care: a structured review of implementation models.

Authors:  Judith Hayward; John McDermott; Nadeem Qureshi; William Newman
Journal:  Pharmacogenomics       Date:  2021-09-01       Impact factor: 2.533

8.  Delivering pharmacogenetic testing in a primary care setting.

Authors:  Rachel Mills; Deepak Voora; Bruce Peyser; Susanne B Haga
Journal:  Pharmgenomics Pers Med       Date:  2013-09-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.